Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12,344 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical impacts of tumor cell contamination of hematopoietic stem cell products in metastatic breast cancer patients undergoing autologous peripheral blood stem cell transplantation: multicenter trial.
Ahn MJ, Noh YH, Lee YS, Lee YY, Choi IY, Kim IS, Joh EK, Shin DB, Kim SY, Cho KS, Kim HC, Kim HS, Suh CW, Kim SH, Lee JA, Park YS. Ahn MJ, et al. Among authors: kim sh, kim sy, kim is, kim hc, kim hs. J Korean Med Sci. 2001 Apr;16(2):175-82. doi: 10.3346/jkms.2001.16.2.175. J Korean Med Sci. 2001. PMID: 11306743 Free PMC article. Clinical Trial.
A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer.
Kim NK, Park YS, Heo DS, Suh C, Kim SY, Park KC, Kang YK, Shin DB, Kim HT, Kim HJ, et al. Kim NK, et al. Among authors: kim hj, kim sy, kim ht. Cancer. 1993 Jun 15;71(12):3813-8. doi: 10.1002/1097-0142(19930615)71:12<3813::aid-cncr2820711205>3.0.co;2-5. Cancer. 1993. PMID: 8508349 Clinical Trial.
Ramosetron for the prevention of cisplatin-induced acute emesis: a prospective randomized comparison with granisetron.
Kang YK, Park YH, Ryoo BY, Bang YJ, Cho KS, Shin DB, Kim HC, Lee KH, Park YS, Lee KS, Heo DS, Kim SY, Cho EK, Lim HY, Kim WK, Lee JA, Kim TY, Lee JC, Yoon HJ, Kim NK. Kang YK, et al. Among authors: kim wk, kim ty, kim sy, kim hc, kim nk. J Int Med Res. 2002 May-Jun;30(3):220-9. doi: 10.1177/147323000203000302. J Int Med Res. 2002. PMID: 12166338 Free article. Clinical Trial.
Improved therapeutic outcomes of DLBCL after introduction of rituximab in Korean patients.
Park YH, Lee JJ, Ryu MH, Kim SY, Kim DH, Do YR, Lee KH, Oh SJ, Kim YK, Suh CW, Heo DS, Ryoo BY, Kim JK, Song HS, Lee WS, Kim HJ, Bang YJ, Yang SH, Sohn SK, Kang YK; Lymphoma Study Division of the Korean Cancer Study Group. Park YH, et al. Among authors: kim jk, kim yk, kim hj, kim dh, kim sy. Ann Hematol. 2006 Apr;85(4):257-62. doi: 10.1007/s00277-005-0060-6. Epub 2006 Jan 17. Ann Hematol. 2006. PMID: 16416337
Alterations of Fas (Apo-1/CD95) gene in non-small cell lung cancer.
Lee SH, Shin MS, Park WS, Kim SY, Kim HS, Han JY, Park GS, Dong SM, Pi JH, Kim CS, Kim SH, Lee JY, Yoo NJ. Lee SH, et al. Among authors: kim cs, kim sh, kim sy, kim hs. Oncogene. 1999 Jun 24;18(25):3754-60. doi: 10.1038/sj.onc.1202769. Oncogene. 1999. PMID: 10391683
12,344 results
You have reached the last available page of results. Please see the User Guide for more information.